RxDoctor Payments Data

Angela Ball

Nurse Practitioner · Osceola, INNPI 1093479370

Payments from drug & device makers

$912in general payments, 2019–2025

Across 43 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$108
  • Inogen, Inc.$94
  • AbbVie$93
  • Mylan Specialty L.p.$81
  • Lundbeck LLC$55
  • Merck$52
  • plus $429 from 14 others

What the payments were for

  • Food & beverage$912100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$912 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$21,388
Medicare patients
131
Services billed
1,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$39,403
FarxigaDapagliflozin Propanediol27$25,649
JardianceEmpagliflozin28$18,154
OzempicSemaglutide12$17,263
MounjaroTirzepatide17$16,964
RybelsusSemaglutide13$15,963
XareltoRivaroxaban12$11,270
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$10,572
LinzessLinaclotide12$9,471
Albuterol Sulfate HfaAlbuterol Sulfate58$3,406
Ventolin HfaAlbuterol Sulfate18$1,675
Gabapentin73$1,357
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$1,286
Atorvastatin Calcium125$1,213
Losartan Potassium109$1,115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$14$36,22040 claims
Novo NordiskOzempic, Rybelsus$108$33,22625 claims
Boehringer IngelheimJardiance$31$18,15428 claims
Lilly USA, LLCMounjaro$34$16,96417 claims
AbbVieLinzess$93$9,47112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Osceola

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →